Daniel A Arber

40PUBLICATIONS
232CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Oct 05, 2026
Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 study.

|Nov 12, 2025
Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).

Robert Jeraj, Fenghai Duan, Ryan J Mattison

|Oct 18, 2025
Acute Leukemias of Ambiguous Lineage With RUNX1 Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With RUNX1 Mutations: A Study From the Bone Marrow Pathology Group.

Timothy J Kirtek, Weina Chen, Jaryse C Harris

|Aug 14, 2025
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults.

Ethan J Harris, Diren Arda Karaoglu, Madina Sukhanova

|Jul 03, 2025
Systemic Mastocytosis in 910 Patients: Prognostic Contribution of the International Consensus Classification in the Context of the Mayo Alliance Prognostic System.

Fnu Aperna, Maymona G Abdelmagid, Mahesh Kumar

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

Pageof 7

Frequent Collaborators

15 joint publications

Attilio Orazi

13 joint publications

Ayalew Tefferi

10 joint publications

Naseema Gangat

8 joint publications

Talha Badar